Peregrine Pharmaceuticals shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.4M | 559k | 11.38 |
| 2023-12-31 | $351k | 54k | 6.50 |
| 2023-06-30 | $2.2M | 161k | 13.97 |
| 2023-03-31 | $2.4M | 127k | 18.75 |
| 2022-12-31 | $2.8M | 205k | 13.77 |
| 2022-09-30 | $632k | 33k | 19.11 |
| 2022-06-30 | $485k | 32k | 15.24 |
| 2022-03-31 | $710k | 35k | 20.36 |
| 2021-12-31 | $1.1M | 36k | 29.16 |
| 2021-09-30 | $98k | 4.6k | 21.37 |
| 2021-06-30 | $118k | 4.6k | 25.65 |
| 2021-03-31 | $70k | 3.9k | 18.16 |
| 2020-09-30 | $64k | 8.4k | 7.60 |
| 2019-12-31 | $4.0k | 600 | 6.67 |